NL-OMON54785尚未招募2 期
Inhibition of Mast cell Activation in AtheroScleroTic lesions using an Anti-IgE antibody approach (MAST-trial) - MAST
niversitair Medisch Centrum Utrecht0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Patient has a symptomatic or asymptomatic atherosclerotic carotid artery
- •stenosis of at least 50% narrowing of the lumen (calculated by using criteria
- •equivalent to the NASCET method) wherefore revascularisation through carotid
- •endarterectomy is planned routinely.
排除标准
- •Any anaphylactic reaction in the medical history
研究者
相似试验
进行中（未招募）
1 期
Medication for inhibition of activation of a certain immune cell in atherosclerotic lesionsAtherosclerosisEUCTR2019-002452-16-NLMC Utrecht80
进行中（未招募）
1 期
Inhibition of Mast cell Activation in AtheroScleroTic lesions using an Anti-IgE antibody approach (MAST)MedDRA version: 24.1Level: LLTClassification code: 10029992Term: Occlusion and stenosis of carotid artery Class: 10029205MedDRA version: 21.1Level: LLTClassification code: 10081245Term: External carotid artery stenosis Class: 10029205MedDRA version: 20.0Level: PTClassification code: 10007687Term: Carotid artery stenosis Class: 100000004852MedDRA version: 21.1Level: LLTClassification code: 10081244Term: Internal carotid artery stenosis Class: 10029205Carotid artery stenosisCTIS2024-513581-19-00niversitair Medisch Centrum Utrecht40
招募中
不适用
Inhibition of Mast cell Activation in AtheroScleroTic lesions using an Anti-IgE antibody approach (MAST)Atherosclerotic narrowing of the carotid arteryNL-OMON23598ZonMW, Dutch Heart Foundation80
招募中
1 期
Clinical study for the treatment of atherosclerotic angiopathy with traditional Chinese MedicineatherosclerosisITMCTR1900002732Hebei Petro China Central Hospital
已完成
不适用
Prevention of atherosclerosis by SGLT2 inhibitor; multicenter, randomized controlled studyType 2 diabetesJPRN-UMIN000018440Department of Cardiovascular Medicine, Saga University479